Back

The Karius Test

The Karius Test^™ is a liquid biopsy that can non-invasively and rapidly detect over 1000 pathogens causing both deep-seated and bloodstream infections from a single blood sample. The Karius Test helps clinicians avoid invasive, low-yield, and sequential diagnostic tests that can delay treatment for the most vulnerable hospitalized patients.

Learn More About the Karius Test

Peer-reviewed publications, abstracts and clinical trials have evaluated the Karius Test and shown its efficacy in detecting pathogens in various clinical contexts.

View Clinical Evidence

Karius seeks to provide clinicians with diagnostic answers that lead to patients receiving timely, effective treatments.

View About

Featured:

Click here to learn more about the Karius Mobile App

Clinical Evidence

Clinical Studies

Published, peer-reviewed studies show the clinical impact of the Karius Test^™ in institutions around the country

40+

Peer-reviewed publications

View

70+

Abstracts

View

10

Clinical trials

View

Order the Karius Test

Plasma Microbial Cell–free DNA Next Generation Sequencing in the Diagnosis and Management of Febrile Neutropenia

In a prospective study of patients with febrile neutropenia, compared to standard microbiology testing, the Karius Test was twice as likely to provide a microbiological diagnosis, often without resorting to invasive diagnostic procedures.

View publication

Scientific publications, case studies, and clinical trials

Search through multiple publications showing the efficacy of the Karius Test.

Peer-reviewed Publications

View abstracts that evaluated the metagenomic sequencing of the Karius Test.

Abstracts

View clinical trials validating the Karius Test’s ability to detect pathogens in various clinical contexts.

Clinical Trials

Karius Webinar Rounds

View presentations given by physicians who have used the Karius Test to rapidly and non-invasively diagnose infections in their patients.

Watch Now

Biopharma Applications

Partner with Karius to discover new biomarkers and develop assays that can help you select patients, predict response, enable early detection, and monitor disease progression and remission.

Learn More